Author Topic: COVID-19 vaccine: Practical clinical considerations  (Read 28 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
COVID-19 vaccine: Practical clinical considerations
« on: March 30, 2021, 07:16:59 pm »
From Annals of Internal Medicine (March 26, 2021), a panel discussion to answer questions about the COVID-19 vaccines:


https://www.acpjournals.org/doi/10.7326/M21-1260
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
33 Views
Last post November 30, 2020, 03:46:43 pm
by agate
0 Replies
55 Views
Last post January 13, 2021, 02:32:50 pm
by agate
0 Replies
20 Views
Last post March 24, 2021, 09:22:10 pm
by agate
0 Replies
35 Views
Last post March 29, 2021, 08:50:37 pm
by agate
0 Replies
46 Views
Last post April 02, 2021, 09:24:09 pm
by agate